About
Small Molecules, radiopharmaceutical imaging
Areas of Focus
Categories
Small Molecule PharmaceuticalRadiopharmaceuticalsMidwest
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
228
By Phase
PHASE1: 3PHASE2/PHASE3: 1
By Status
RECRUITING: 2TERMINATED: 2AVAILABLE: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06617169Lead Sponsor
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
PHASE1Recruiting
12 participants
Started: Oct 8, 2024 · Completed: Jan 31, 2027
NCT06337084Lead Sponsor
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
PHASE1Recruiting
12 participants
Started: May 30, 2024 · Completed: Apr 30, 2026
NCT05043649Lead Sponsor
Camsirubicin + Pegfilgrastim to Determine MTD in ASTS
PHASE1Terminated
14 participants
Started: Sep 22, 2021 · Completed: May 13, 2024
NCT04648020Lead Sponsor
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.
PHASE2/PHASE3Terminated
190 participants
Started: Feb 11, 2021 · Completed: May 14, 2023
NCT06980506Lead Sponsor
MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
N/AAVAILABLE
Locations (1)
Headquarters
Wilmette, IL, United States
Map
Loading map...